KNTE News
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE
Kinnate Biopharma Inc. vende su inhibidor Pan-RAF en fase de investigación, exarafenib, a Pierre Fabre Laboratories
Kinnate Biopharma Inc. verkauft seinen in der Entwicklung befindlichen Pan-RAF-Inhibitor, Exarafenib an Pierre Fabre Laboratories
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DFS, COF, KNTE
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, KNTE, CALB
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, KNTE, CALB
KNTE Events
No data
KNTE Monitor News
No data
KNTE Earnings Analysis